
COVID-19 bivalent booster vaccines – important update
The recent availability of the Moderna Spikevax Bivalent Booster Vaccine has seen a rise in the number of vaccine-related calls and incident reports to PDL.
Practice Alerts

The recent availability of the Moderna Spikevax Bivalent Booster Vaccine has seen a rise in the number of vaccine-related calls and incident reports to PDL.

Each year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders

PDL NSW members were recently sent a Forum communique on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health

The Pharmacy Council of NSW has launched a new initiative involving a quarterly forum bringing together key pharmacy stakeholder agencies to discuss issues of relevance

Pharmacists practising in Queensland are advised the UTIPP-Q pilot has finished and the Urinary Tract Infection Community Pharmacy Service is now allowed under the Pharmacists

Pharmacists practising in Queensland are advised that after Friday, 9 September 2022, new pharmacists and pharmacies will no longer be accepted into the UTIPP-Q pilot.

PDL has recently received several incident reports where the incorrect varicella vaccine has been prescribed and/or supplied. Prescribing software programs have variations on how the

It is no surprise that the top four drugs on our list are Schedule 8’s (S8s). Dispensing errors can happen with any drug but the

Schedule 8 medicines, in particular opioids, are often involved in notifications to PDL. An Australian Institute of Health and Welfare report on opioid harm in

PDL is pleased to provide further information to pharmacists practising in Queensland about the UTIPP-Q pilot program and recent announcements. The following advice is directed